上海昊海生物科技股份有限公司（06826）于2026年3月6日披露翌日披露报表，宣布已于2025年12月5日至2025年12月29日期间回购的580,700股H股于2026年3月6日正式注销。该回购股份约占回购前公司已发行H股总数的0.2561%，回购价格为每股26.27港元。注销完成后，H股数量由36,509,740股降至35,929,040股。
公司同时披露A股股本未发生变化，A股数量仍为190,203,760股，另有3,848,095股处于库存状态，总股本相应维持在194,051,855股水平。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律程序。本次公告由公司董秘兼联席公司秘书田敏签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.